Debra Zack's most recent trade in Exagen Inc was a trade of 3,241 Common Stock done at an average price of $7.1 . Disclosure was reported to the exchange on March 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exagen Inc | Debra Zack | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. | 01 Mar 2022 | 3,241 | 84,259 (0%) | 0% | 7.1 | 23,076 | Common Stock |
| Exagen Inc | Debra Zack | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 50,000 | 87,500 (0%) | 0% | 0 | Common Stock |